Advertisement covers ICAAC 2014


What HIV Research Do You Want to Hear About at ICAAC 2014?

September 3, 2014

If you're wondering what to expect at this year's Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), I've provided a preview of what I think will be the most noteworthy studies. However, sometimes at clinical conferences, the voice of the community can be lost or missing. And even though we're all on the same side, it may feel like there's a disconnect between the people affected by HIV and the researchers who study to fight HIV.

Well, will be covering the conference from Sept. 5-9, so here's your chance to let us know what you think.

What HIV research would you like to hear about the most?

What questions would you want to ask clinicians and researchers?

Let us know in the comments. Thanks!

Warren Tong is the research editor for and

Follow Warren on Twitter: @WarrenAtTheBody.

Copyright © 2014 Remedy Health Media, LLC. All rights reserved.

This article was provided by TheBodyPRO. It is a part of the publication The 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2014).


Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.